• Study reports abnormally high VTE and high bleed risk in critically ill COVID-19 patients and calls for more effective prevention strategies.
  • Clinicians at NHS hospitals are supporting the care of COVID-19 patients with the use of geko™ devices to reduce the risk of blood clots in the most at risk patients.
Learn more Contact us

Partnering with healthcare professionals to help solve challenging medical problems

geko™ devices

VTE Prevention

Royal Stoke University Hospital, UHNM NHS Trust

Reducing VTE risk in acute stroke patients

View Partner

Pre-operative oedema reduction

The James Cook University Hospital, South Tees Hospitals NHS Foundation Trust

Accelerating readiness for theatre
in ankle fracture patients

View Partner

Post-operative oedema prevention

Spire Edinburgh Hospital, Murrayfield

Preventing post-operative oedema formation
in foot & ankle surgery

View Partner

Wound Therapy

Welsh Wound Innovation Centre
& The University of Cardiff,
School of Medicine

Breaking the cycle of chronic wounds

View Partner

Wound therapy

Countess of Chester Hospital
NHS Foundation Trust

Accelerating closure of hard-to-heal complex wounds

View Partner

OnPulse Technology

The revolutionary neuromuscular electrostimulation technology developed by Firstkind

Find out more

geko™ product

Hospital Applications Device

Find out more

geko™ product

Wound Therapy Applications Device

Find out more

Partner with us

What can the geko™ do for my patients?

News

The Sunday Times article – Clot-busters to tackle coronavirus patients’ blood problems

News

Rachel Fallon, CTO Sky Medical Technology Ltd, speaks to Women of Wearables (WoW) about the challenges for women in STEM (Science, technology , engineering and Maths)

News

Changing clinical practice: The burden of post-stroke VTE prevention